Organisation: National Cancer Control Programme Technology Review Committee

Sign in

Organisation: National Cancer Control Programme Technology Review Committee

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Skin cancer patients may miss out on costly new drug

Skin cancer patients may miss out on costly new drug

Patients suffering from skin cancer could be set to miss out on a groundbreaking blockbuster drug.

Sat, 26 Mar, 2016